The European Data Protection Board (EDPB) has released guidelines clarifying the role of pseudonymization in meeting General Data Protection Regulation (GDPR) obligations, emphasizing its importance as a data protection measure while still classifying pseudonymized data as personal data if it can be linked to individuals.
The Federal Trade Commission’s report highlights potential antitrust issues stemming from partnerships between major cloud service providers and AI developers, emphasizing the need for regulatory scrutiny to ensure competitive fairness in the rapidly evolving AI landscape.
As AI and machine learning revolutionize healthcare by enhancing drug development and clinical decision-making, the Federation of State Medical Boards emphasizes the importance of professional judgment and accountability for physicians in response to AI recommendations.
The American Bar Association’s Formal Opinion 512 outlines ethical obligations for attorneys using generative AI tools, emphasizing competency, confidentiality, and effective communication while navigating the challenges and opportunities presented by AI in legal practice.
The Department of Justice has significantly increased its AI Use Case Inventory to 241 entries in 2024, as mandated by Executive Order 14110, to enhance innovation and manage rights and safety impacts associated with AI technologies.
In 2024, significant legislative and regulatory developments emerged worldwide, including comprehensive AI laws in several U.S. states, the enforcement of the EU AI Act, and international treaties aimed at ensuring transparency, accountability, and safety in AI technologies.
